id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-102456-6jt4ksha	Taylor-Cousar, Jennifer L.	How I Do It: Restarting Respiratory Clinical Research in the Era of the COVID19 Pandemic	2020-11-13		.txt	text/plain	4068	168	35	However, now that we have navigated the initial surge of SARS-CoV-2 cases, many are considering how to reintroduce non-COVID-19 clinical research conduct while protecting participants, staff and ensuring data integrity. Here we review key considerations and suggest a step-wise approach for resuming clinical research including observational research, registry trials, and interventional trials, as well as potential data confounding related to COVID-19 infections that are important to consider as research studies restart and data are analyzed. In the spirit of "Do No Harm", it is critical that institutional policies and processes are in place to ensure that there is no significant additional risk of contracting viral respiratory or other infections in the normal course of participation in research studies; now during the COVID-19 pandemic, these principles are even more critical. Throughout the subject's participation in clinical research during the pandemic, she expressed her appreciation for the opportunity to continue in the study from which she believed she was benefiting, with minimal risk of exposure to infection from SARS-CoV-2.	./cache/cord-102456-6jt4ksha.txt	./txt/cord-102456-6jt4ksha.txt